SightfileU.S. market data from official filings

MODERNA INC (MRNA)

Name: MODERNA INC (MRNA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001682852 · EDGAR filings · Updated 2026-07-24

MODERNA INC (MRNA) has reported institutional ownership of 77.7%, with 718 institutional managers holding positions valued at $15.6B per the latest 13F reporting period.

Institutional ownership

77.7%

Institutional managers

718

Reported 13F value

$15.6B

Insider activity

112 trans.

−$9.27M net selling

Filings this week (1)

2026-07-24 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-16 — Insider transaction reported (Form 4)
2026-07-15 — Notice of proposed sale filed (Form 144)
2026-07-10 — Insider transaction reported (Form 4)
2026-07-10 — Initial insider ownership filed (Form 3)
2026-07-08 — Current report (8-K) filed
2026-07-07 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)
2026-06-30 — Initial insider ownership filed (Form 3)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MODERNA INC has 718 institutional holders and institutional ownership of 77.7%.

#	Institution	Reported value	% of tracked total
1	FMR LLC	$2.32B	14.8%
2	BlackRock, Inc.	$1.51B	9.6%
3	VANGUARD CAPITAL MANAGEMENT LLC	$1.16B	7.4%
4	BAILLIE GIFFORD & CO	$1.02B	6.5%
5	Capital World Investors	$949.8M	6.1%
6	VANGUARD PORTFOLIO MANAGEMENT LLC	$793.3M	5.1%
7	STATE STREET CORP	$755.0M	4.8%
8	GEODE CAPITAL MANAGEMENT, LLC	$478.5M	3.1%
9	TWO SIGMA INVESTMENTS, LP	$461.6M	3.0%
10	MORGAN STANLEY	$430.3M	2.8%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 112 transactions (0 buys, 5 sells) across 9 reporting insiders, with a net reported value of −$9.27M.

Quarterly net insider value, as reported in Form 4 filings.

Fails-to-deliver

The SEC's fails-to-deliver file for 2026-06-30 reports 60,788 failed-to-deliver shares ($3.26M) for MRNA — an official data point published by the SEC, shown as reported.

Related companies

ZIMMER BIOMET HLDGS INC (ZBH) · ALCON AG (ALC) · ROYALTY PHARMA PLC CLASS A (RPRX) · TENET HEALTHCARE CORP (THC) · ROIVANT SCIENCES LTD (ROIV) · COOPER COS INC (COO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.